Skip to main content
. Author manuscript; available in PMC: 2009 Sep 24.
Published in final edited form as: Arthritis Rheum. 2009 Apr;60(4):1179–1186. doi: 10.1002/art.24418

Figure 2.

Figure 2

Percentage of cases and controls with 1 or 2 treatment-resistant Lyme arthritis–associated HLA–DRB1 alleles. There were no statistically significant differences between groups. For the percentage of DRB1*0401-positive cases versus the percentage of DRB1*0401-positive arthritis controls, the difference approached nominal statistical significance (P = 0.054).